Two Sigma Advisers’s Arcellx ACLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,600
Closed -$429K 2363
2024
Q4
$429K Buy
5,600
+1,100
+24% +$95K ﹤0.01% 1839
2024
Q3
$376K Sell
4,500
-800
-15% -$53.3K ﹤0.01% 1826
2024
Q2
$293K Sell
5,300
-43,100
-89% -$2.34M ﹤0.01% 2077
2024
Q1
$3.37M Buy
48,400
+40,600
+521% +$2.57M 0.01% 956
2023
Q4
$433K Sell
7,800
-33,900
-81% -$1.53M ﹤0.01% 1976
2023
Q3
$1.5M Sell
41,700
-88,100
-68% -$3.04M ﹤0.01% 1341
2023
Q2
$4.1M Buy
129,800
+76,200
+142% +$2.91M 0.01% 857
2023
Q1
$1.65M Buy
53,600
+22,300
+71% +$676K ﹤0.01% 1372
2022
Q4
$970K Buy
+31,300
New +$718K ﹤0.01% 1581

Other funds holding ACLX

Two Sigma Advisers's ACLX Position: Q1 2025 in Review

Two Sigma Advisers sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 5,600 shares — an estimated $429K sold.

Two Sigma Advisers first reported a position in ACLX in Q4 2022 and held it in 9 quarters. The position peaked at $4.1M in Q2 2023. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

  • Two Sigma Advisers reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 5,600 Arcellx shares in Q1 2025, an estimated $429K.
  • Two Sigma Advisers first reported a position in Arcellx in Q4 2022 and held it in 9 quarters.
  • Two Sigma Advisers's Arcellx position peaked at $4.1M in Q2 2023.
  • 197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.